Press release
Chronic Kidney Disease Market Expansion Continues, with Forecast Valuation of $95.43 Billion by 2029
Chronic Kidney Disease Market
Chronic Kidney Disease Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The worldwide market for chronic kidney disease has experienced robust expansion lately, set to increase from a valuation of $70.65 billion in the year 2024 to reach $74.87 billion by 2025, reflecting a compound annual growth rate of 6.0%; this upward trajectory during the past period has been fueled by factors such as the widespread prevalence of hypertension and diabetes, an increasing global elderly demographic, adoption of detrimental lifestyle habits, significant gaps in healthcare availability, and ongoing progress in medical technology.
Chronic Kidney Disease Market Size Forecast: What's the Projected Valuation by 2029?
Anticipation surrounds the chronic kidney disease sector, projecting robust expansion ahead; this market is slated to reach a valuation of $95.43 billion by the year 2029, underpinned by a compound annual growth rate (CAGR) of 6.3%, with this upward trajectory being fueled by intensified governmental focus on healthcare policies, advancements in personalized medical treatments, escalating prevalence of obesity, the broader increase in long-term health conditions, and enhanced availability of medical services. Key developments shaping this timeframe encompass proactive measures such as expanded early detection drives, the increasing utilization of remote patient oversight and virtual care platforms, initiatives designed to place greater control in patients' hands, movements toward localized healthcare provision, and the incorporation of dietary management as a therapeutic component.
View the full report here:
https://www.thebusinessresearchcompany.com/report/chronic-kidney-disease-global-market-report
What Are the Drivers Transforming the Chronic Kidney Disease Market?
Anticipated expansion in the incidence of renal ailments is projected to be the catalyst for the expansion of the market segment dedicated to chronic kidney disease moving ahead. Renal disorders encompass a collection of pathologies that impact the functional capacity and architectural integrity of the kidneys. Therapies prescribed for kidney ailments serve the dual purpose of regulating hypertension in affected individuals and diminishing protein leakage, thereby aiming to arrest the deterioration of renal function, alleviate attendant symptoms, and avert potential adverse outcomes. As an illustration, data released by the Centers for Disease Control and Prevention, a prominent national health organization in the United States, indicated that as of July 2022, approximately fifteen percent of the US population, equating to roughly 37 million individuals, were living with some form of kidney disease; consequently, this escalating rate of kidney ailments underpins the momentum fueling the expansion within the chronic kidney disease marketplace.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11969&type=smp
What Long-Term Trends Will Define the Future of the Chronic Kidney Disease Market?
A significant development gaining traction within the arena of chronic kidney disease involves advancements in product offerings, as market participants actively pursue novel solutions to secure and enhance their competitive standing; for example, Germany's Bayer introduced the groundbreaking medication Kerendia (finerenone) in August 2022, specifically designed to impede the advancement of CKD among diabetic populations, which represents a pioneering, non-steroidal, selective mineralocorticoid receptor antagonist unlike therapies currently available, functioning by inhibiting the excessive stimulation of the mineralocorticoid receptor (MR) that drives both the worsening of CKD and cardiovascular harm.
Which Segments in the Chronic Kidney Disease Market Offer the Most Profit Potential?
The chronic kidney diseasemarket covered in this report is segmented -
1) By Diagnosis: Blood Test; Urine Test; Imaging Test; Kidney Biopsy
2) By Treatment: Drugs; Dialysis; Kidney Transplant; ACE Inhibitors; Blood Test; Other Treatments
3) By Route of Administration: Oral; Intravenous; Subcutaneous
4) By End-User: Hospital And Clinics; Ambulatory Surgery Centers (ASCs); Dialysis Centers; Other End-Users
Subsegments:
1) By Blood Test: Serum Creatinine Test; Glomerular Filtration Rate (GFR) Test; Blood Urea Nitrogen (BUN) Test; Electrolyte Tests
2) By Urine Test: Urinalysis; 24-hour Urine Collection; Urine Protein Test; Urine Albumin-To-Creatinine Ratio (ACR)
3) By Imaging Test: Ultrasound; CT Scan; MRI; X-ray
4) By Kidney Biopsy: Percutaneous Kidney Biopsy; Open Kidney Biopsy; Laparoscopic Kidney Biopsy
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=11969&type=smp
Which Firms Dominate the Chronic Kidney Disease Market by Market Share and Revenue in 2025?
Major companies operating in the chronic kidney disease market include Pfizer Inc, Johnson and Johnson Services Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott laboratories Inc., GlaxoSmithKline PLC, Takeda Pharmaceuticals Ltd., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Novo Nordisk AS, Siemens Healthineers AG, AstraZeneca Pharmaceuticals LP, Teva Pharmaceutical Industries Ltd., Beckman Coulter Inc., Kissei Pharmaceutical Co. Ltd., Akebia Therapeutics Inc., Mission Therapeutics Ltd., Tricida Inc., Regulus Therapeutics Inc., Goldfinch Bio Co, Alio Inc., Monogram Health, Strive Health, Maze Therapeutics, ProKidney Corp
Which Regions Offer the Highest Growth Potential in the Chronic Kidney Disease Market?
North America was the largest region in the chronic kidney disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11969
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chronic Kidney Disease Market Expansion Continues, with Forecast Valuation of $95.43 Billion by 2029 here
News-ID: 4270455 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Kidney
Chronic Kidney Diseases Fueling Kidney Stone Retrieval Device Growth Driving Mar …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Kidney Stone Retrieval Devices Market Size By 2025?
In recent times, the market size for kidney stone retrieval devices has seen consistent growth. The market, which is projected to increase from $2.84 billion in 2024 to $2.96 billion in 2025, forecasts a compound annual growth…
Wearable Artificial Kidney Market Development Trajectory through 2031 Dutch Kidn …
"[New York, December 2024] The Wearable Artificial Kidney represents a groundbreaking innovation in nephrology that combines advanced biomedical engineering with portable technology. Designed to continuously filter waste from the blood, this device caters primarily to patients with chronic kidney disease. As renal health issues become more prevalent globally, the relevance of the Wearable Artificial Kidney lies in its potential to enhance patient quality of life, providing a more convenient and…
Kidney Dialysis Market Share Kidney Dialysis Market
According to Ameco Research 'Kidney Dialysis Market report, the analysts took this into account when estimating the Kidney Dialysis Market size and CAGR for the respective industry. The report's author has thoroughly examined the market and concluded that the Kidney Dialysis Market 's growth will level off in the coming years. In addition to that, the prominent qualitative information added in the report includes Kidney Dialysis Market trends, segmentation, key…
Kidney Health Journey: Polycystic Kidney Disease Drug Pipeline Landscape (2023-2 …
Market Outlook:
The Polycystic Kidney Disease (PKD) drug pipeline landscape is poised for noteworthy advancements, offering a positive outlook for those navigating the complex journey of kidney health. As PKD poses a significant global health burden, the market outlook reflects a pressing need for innovative pharmaceutical interventions to address the challenges associated with this genetic disorder. With ongoing research and development efforts, the PKD drug pipeline is positioned to bring…
Kidney Balloon Market Growth Drives By Rising Prevalence of Kidney Stone and Oth …
Demand Analysis of Kidney Balloon Market Overview:
Kidney Balloon Market is predicted to grow at a moderate CAGR of 5.2% during the forecast period covering 2022 to 2029. Kidney Balloon Market share is estimated to reach a value of nearly US$ 2.50 Billion by 2029.
The "Kidney Balloon Market" think about 2022, the industry landscape is secured from driving factors to upstream markets and the by and large state of the market.…
Artificial Kidney Market Report 2018: Segmentation by Type (Wearable Artificial …
Global Artificial Kidney market research report provides company profile for Medtronic, DaVita, Merit Medical Systems, NIPRO Medical Corporation, Nikkiso, B. Braun Melsungen AG, Kawasumi Laboratories, Fresenius, Baxter, Asahi Kasei Medical, Xcorporeal and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for…
